| Ytd | 27.92% | |
| 1y | -68.42% |
| Open | 17.48 | Prev Close | 17.33 | Low | 16.83 | High | 17.48 | Mkt Cap | 1.42B |
| Vol | 93.23K | Avg Vol | 1.13M | EPS | -3.87 | P/E | -4.35 | Forward P/E | -5.41 |
| Beta | 1.06 | Short Ratio | 4.07 | Inst. Own | 78.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 19.02 | 200-d Avg | 16.42 | 1yr Est | 28.00 |
MoonLake Immunotherapeutics (NASDAQ: MLTX - Get Free Report) was the recipient of some unusual optio
MoonLake Immunotherapeutics said on Monday its experimental drug met all main goals in a late-stage
Phase 3 IZAR-1 trial in bio-naïve patients met all clinical endpoints at Week 16 for 60 mg sonelokim
Arrowstreet Capital Limited Partnership bought a new stake in MoonLake Immunotherapeutics (NASDAQ: M
U.S. stock futures mixed, Nasdaq 100 up 100 points. FedEx falls after Q4 results, beating estimates
U.S. stocks up with Dow Jones gaining 200+ points. AbbVie Inc. announced acquisition of Apogee Thera
SAGTEC GLOBAL (NASDAQ: SAGT) gained 75.6% in pre-market trading after projecting 35% revenue growth
Top Wall Street analysts upgraded APA Corp. & MoonLake Immunotherapeutics, see why & what ot
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The comp
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday'
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Mo
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announce
Byron Allen dials out, Salesforce logs in. Here are the various deal announcements of the past week
Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durabil